SREBF2 and steatosis: With regard to the mRNA gene expression of lipid metabolism, predominant Ld-MaS compared to nil-Steatosis was significantly associated with low liver graft NPC1L1 (O.R. 0.137 [CI 0.031–0.603]; p = 0.009), SREBP-2 (O.R. 0.762 [CI 0.600–0.968]; p = 0.026) and PNPLA3 (O.R. 0.916 [CI 0.844–0.995]; p = 0.038) mRNA expression (Figure 4).